Halozyme Therapeutics (HALO US)

Analysis

Health Care • United States

Halozyme Therapeutics, Inc. is a biopharmaceutical company developing products for the diabetes, cancer, dermatology and drug delivery markets. The Company's platform technology is based on recombinant human hyaluronidase plus additional enzymes. Halozyme applies its technology to its proprietary programs and to partnerships with pharmaceutical companies.

Refresh

Company Presentation • 17 Jan 2024 20:00

Corporate presentation

Company Presentation • 02 Dec 2024 20:00

Corporate presentation

Company Presentation • 08 Mar 2024 20:00

Corporate presentation

Company Presentation • 12 Jun 2024 20:00

Corporate presentation

Company Presentation • 18 Sep 2023 20:00

Price Gauge
52-week Range	0.00 - 0.00
Market Cap (USDm)	0.00
P/E	0.00
Dividend (Yield)	0.00

Corporate presentation

Corporate presentation

Corporate presentation

Corporate presentation

Investor presentation